AI Verdict
RPRX has stronger fundamentals based on our AI analysis.
RRX vs RPRX Fundamental Comparison
| Metric | RRX | RPRX |
|---|---|---|
| Revenue | $5.9B | $2.4B |
| Net Income | $279.5M | $770.9M |
| Net Margin | 4.7% | 32.4% |
| ROE | 4.1% | 7.9% |
| ROA | 2.0% | 3.9% |
| Current Ratio | 2.15x | 2.40x |
| Debt/Equity | 0.70x | 0.92x |
| EPS | $4.20 | $1.78 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RRX vs RPRX: Frequently Asked Questions
Is RRX or RPRX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RPRX has stronger fundamentals. RRX is rated HOLD (72% confidence) while RPRX is rated HOLD (75% confidence). This is not investment advice.
How does RRX compare to RPRX fundamentally?
REGAL REXNORD CORP has ROE of 4.1% vs Royalty Pharma plc's 7.9%. Net margins are 4.7% vs 32.4% respectively.
Which stock pays higher dividends, RRX or RPRX?
RRX has a dividend yield of N/A or no dividend while RPRX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RRX or RPRX for long term?
For long-term investing, consider that RRX has HOLD rating with 72% confidence, while RPRX has HOLD rating with 75% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RRX vs RPRX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RRX vs RPRX, the AI consensus favors RPRX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.